PO.2.43 The activity and damage index in systemic lupus erythematosus depending on antiphospholipid antibodies

PO.2.43 The activity and damage index in systemic lupus erythematosus depending on antiphospholipid antibodies

Bibliographic Details
Main Authors:	T Reshetnyak, A Lila, F Cheldieva, A Shumilova, M Cherkasova
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
by: Tatiana Reshetnyak, et al.
Published: (2022-08-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

PO.2.42 The value of IGA-ACL and IGA-AB2-GP1 in clinical and laboratory manifestations of systemic lupus erythematosus
by: T Reshetnyak, et al.
Published: (2022-10-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Assessment of the activity and organ damage in antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2021-08-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01)

Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Tatiana Reshetnyak, et al.
Published: (2023-05-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)

Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
by: Fariza A. Cheldieva, et al.
Published: (2023-10-01)

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

PO.3.70 Case report of a systemic lupus erythematosus patient with an ulcerative necrotic vasculitis: features of therapeutic approaches
by: T Reshetnyak, et al.
Published: (2022-10-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01)

Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01)

LP-019 Social maladjustment and anxiety-depressive spectrum disorders in system lupus erythematosus and primary antiphospholipid syndrome patients
by: Tatiana Reshetnyak, et al.
Published: (2023-07-01)

Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
by: Creso Abreu Falcão, et al.
Published: (2002-09-01)

Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
by: Fabrizio Conti, et al.
Published: (2012-01-01)

Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome
by: N V Seredavkina, et al.
Published: (2008-06-01)

The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Tatiana Reshetnyak, et al.
Published: (2023-09-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
by: Ryo Hisada, et al.
Published: (2023-03-01)

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
by: Gordana Petrovic, et al.
Published: (2023-02-01)

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
by: Elena Monzón Manzano, et al.
Published: (2020-10-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?
by: R.A. Sinico, et al.
Published: (2011-09-01)

Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features
by: A. A. Shumilova, et al.
Published: (2022-08-01)

Skin lesions in systemic lupus erythematosus. Part 1: classification, etiology, pathogenesis
by: A. A. Shumilova, et al.
Published: (2022-06-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
by: Stephanie L. Savelli, et al.
Published: (2019-05-01)

The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians.
by: Juan-Sebastian Franco, et al.
Published: (2014-01-01)

Perioperative considerations of systemic lupus erythematosus and antiphospholipid syndrome
by: Jyotsna Satish Paranjpe, et al.
Published: (2016-01-01)

Early damage index in systemic lupus erythematosus
by: I A Andrianova, et al.
Published: (2005-10-01)